Paulson Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Buy
1,118
+22
+2% +$22.5K 0.28% 41
2026
Q1
$1.01M Sell
1,096
-7
-0.6% -$7.1K 0.24% 50
2025
Q4
$1.19M Hold
1,103
0.27% 40
2025
Q3
$842K Sell
1,103
-22
-2% -$16.4K 0.2% 56
2025
Q2
$877K Buy
1,125
+167
+17% +$130K 0.23% 50
2025
Q1
$791K Sell
958
-141
-13% -$117K 0.22% 48
2024
Q4
$848K Buy
1,099
+43
+4% +$35.6K 0.23% 48
2024
Q3
$936K Buy
1,056
+7
+0.7% +$6.29K 0.25% 49
2024
Q2
$950K Hold
1,049
0.28% 43
2024
Q1
$816K Sell
1,049
-20
-2% -$14.2K 0.24% 50
2023
Q4
$623K Sell
1,069
-35
-3% -$20.4K 0.2% 58
2023
Q3
$593K Buy
1,104
+258
+30% +$133K 0.21% 61
2023
Q2
$397K Buy
846
+41
+5% +$17.2K 0.14% 83
2023
Q1
$276K Hold
805
0.12% 72
2022
Q4
$295K Hold
805
0.14% 67
2022
Q3
$260K Hold
805
0.14% 62
2022
Q2
$261K Hold
805
0.14% 62
2022
Q1
$231K Hold
805
0.11% 74
2021
Q4
$222K Buy
+805
New +$204K 0.1% 81
2018
Q4
Sell
-2,261
Closed -$249K 126
2018
Q3
$249K Buy
+2,261
New +$226K 0.22% 106
2018
Q1
Sell
-2,053
Closed -$173K 346
2017
Q4
$173K Buy
+2,053
New +$175K 0.15% 119

Other funds holding LLY

Paulson Wealth Management's LLY Position: Q2 2026 in Review

Paulson Wealth Management increased its Eli Lilly (LLY) stake by 2% in Q2 2026, buying an estimated $22.5K and bringing the position to 1,118 shares worth $1.34M. The position accounts for 0.28% of the portfolio, ranked #41.

Paulson Wealth Management first reported a position in LLY in Q4 2017 and has held it in 21 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Paulson Wealth Management held 1,118 shares of Eli Lilly worth $1.34M as of Q2 2026.
  • Paulson Wealth Management bought 22 Eli Lilly shares in Q2 2026, an estimated $22.5K.
  • Eli Lilly made up 0.28% of Paulson Wealth Management's portfolio in Q2 2026, its #41 holding.
  • Paulson Wealth Management first reported a position in Eli Lilly in Q4 2017 and has held it in 21 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Paulson Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.